Together, the above experiments showed that the expression of C7R could improve the antitumor activity of AXL-CAR-T cells against TNBC both in vitro and in vivo and could partly overcome the inhibition of CAR-T cell activity in tumor microenvironment. This evidence concerns the gene AXL and neoplasm.